Your browser doesn't support javascript.
loading
Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis.
Mezochow, Alyssa; Thakur, Kiran T; Zentner, Isaac; Subbian, Selvakumar; Kagan, Leonid; Vinnard, Christopher.
Affiliation
  • Mezochow A; Department of Medicine, University of Pennsylvania, 3400 Spruce, Philadelphia, PA, USA.
  • Thakur KT; Department of Neurology, Columbia University Irving Medical Center, 650 West 168th Street, New York, USA.
  • Zentner I; Public Health Research Institute, New Jersey Medical School, Rutgers University, 225 Warren St, Newark, NJ, USA.
  • Subbian S; Public Health Research Institute, New Jersey Medical School, Rutgers University, 225 Warren St, Newark, NJ, USA.
  • Kagan L; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers University, 160 Frelinghuysen Road, Piscataway, NJ, USA.
  • Vinnard C; Public Health Research Institute, New Jersey Medical School, Rutgers University, 225 Warren St, Newark, NJ, USA. Electronic address: christopher.vinnard@njms.rutgers.edu.
Int J Infect Dis ; 84: 15-21, 2019 Jul.
Article in En | MEDLINE | ID: mdl-31051278

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Rifampin / Tuberculosis, Meningeal / Antitubercular Agents Type of study: Guideline / Health_economic_evaluation Language: En Journal: Int J Infect Dis Year: 2019 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Rifampin / Tuberculosis, Meningeal / Antitubercular Agents Type of study: Guideline / Health_economic_evaluation Language: En Journal: Int J Infect Dis Year: 2019 Type: Article Affiliation country: United States